Position in OBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,738,564
+$327,464 QoQ
Shares Held
5,037,906
0.0% QoQ
Ownership
8.38%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#2
of 77 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $5,486,611,234 across 68 Biotechnology names. OBIO ranks #41 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $681,627,752 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
4,319,496 | $383,484,854 | |
| 3 | CELC |
Celcuity Inc.
|
3,197,200 | $334,491,064 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,163,721 | $310,387,665 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,586,295 | $287,156,333 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
8,085,461 | $286,144,464 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
14,106,187 | $263,926,758 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
3,752,574 | $213,183,728 |
All Filings in OBIO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,738,564 | 5,037,906 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,411,100 | 5,037,906 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $21,278,112 | 5,127,256 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,125,538 | 5,292,556 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,308,050 | 4,592,556 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $19,656,139 | 4,592,556 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $18,370,224 | 4,592,556 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,605,737 | 4,592,556 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $20,748,930 | 2,545,881 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $13,416,792 | 2,545,881 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $22,204,972 | 2,432,089 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $21,207,816 | 2,432,089 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,370,076 | 2,052,868 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $44,584,882 | 2,278,226 | Shares | Sole | 2023-05-16 | |
| 2022-03-31 HSAQ | — | 450,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 HSAQ | — | 450,000 | Shares | Sole | 2022-04-13 | |
| 2021-09-30 HSAQ | — | 450,000 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 HSAQ | — | 450,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 HSAQ | — | 450,000 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 HSAQ | — | 450,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 HSAQ | — | 450,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||